Parkman Healthcare Partners LLC Veracyte, Inc. Transaction History

Parkman Healthcare Partners LLC

$708 Million
Q3 2024

A detailed history of Parkman Healthcare Partners LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Parkman Healthcare Partners LLC holds 129,260 shares of VCYT stock, worth $5.07 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares

129,260

Previous 209,475 38.29%

Holding current value

$5.07 Million

Previous $4.54 Million 3.11%

% of portfolio

0.62%

Previous 0.67%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$21.0 - $35.25 $1.68 Million - $2.83 Million	-80,215 Reduced 38.29%	129,260 $4.4 Million
Q2 2024 Aug 14, 2024	SELL	$18.86 - $23.55 $841,476 - $1.05 Million	-44,617 Reduced 17.56%	209,475 $4.54 Million
Q1 2024 May 15, 2024	BUY	$21.0 - $29.1 $352,296 - $488,181	16,776 Added 7.07%	254,092 $5.63 Million
Q4 2023 Feb 14, 2024	BUY	$19.72 - $28.68 $225,675 - $328,213	11,444 Added 5.07%	237,316 $6.53 Million
Q3 2023 Nov 14, 2023	BUY	$22.33 - $29.92 $310,654 - $416,247	13,912 Added 6.56%	225,872 $5.04 Million
Q2 2023 Aug 11, 2023	BUY	$20.96 - $26.99 $1.96 Million - $2.52 Million	93,338 Added 78.69%	211,960 $5.4 Million
Q1 2023 May 12, 2023	BUY	$20.58 - $27.89 $18,439 - $24,989	896 Added 0.76%	118,622 $2.65 Million
Q4 2022 Feb 13, 2023	BUY	$15.31 - $29.94 $870,266 - $1.7 Million	56,843 Added 93.36%	117,726 $2.79 Million
Q3 2022 Nov 14, 2022	SELL	$16.58 - $27.9 $216,916 - $365,015	-13,083 Reduced 17.69%	60,883 $1.01 Million
Q2 2022 Aug 12, 2022	BUY	$15.45 - $29.52 $205,716 - $393,058	13,315 Added 21.95%	73,966 $1.47 Million
Q1 2022 May 13, 2022	SELL	$21.94 - $42.51 $35,389 - $68,568	-1,613 Reduced 2.59%	60,651 $1.67 Million
Q4 2021 Feb 11, 2022	BUY	$36.09 - $53.79 $623,057 - $928,630	17,264 Added 38.36%	62,264 $2.57 Million
Q3 2021 Nov 12, 2021	BUY	$35.62 - $52.97 $1.6 Million - $2.38 Million	45,000 New	45,000 $2.09 Million

Others Institutions Holding VCYT

# of Institutions

308

Shares Held

81.8M

Call Options Held

134K

Put Options Held

13.3K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.81B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parkman Healthcare Partners LLC with notifications on news.

Account

Parkman Healthcare Partners LLC Veracyte, Inc. Transaction History